Orchestrating AlphaFold 3 & 2 with Python: Handling AI Hallucinations using Adapter Patter (Trinity Protocol Part 1)

AI models are good at looking confident even when they're wrong. In protein structure prediction, this is a problem - you can't tell if AlphaFold hallucinated a binding pocket until you've spent months and money trying to validate it experimentally.

We built a system that cross-checks predictions using three independent AI models running in an autonomous refinement loop. Here's how it works and what we learned.

1️⃣The Core Problem

When you ask AlphaFold to predict a protein-ligand complex, you get back:

3D coordinates (looks great in PyMOL)

Confidence scores (pLDDT, pTM, ipTM)

A ranking score

But high confidence doesn't mean correct structure. The model can be confidently wrong, especially for:

Novel binding modes

Flexible loops

Protein-protein interfaces

Ligands outside the training set

Traditional solution: Run the prediction multiple times with different seeds, check RMSD.

Problem with that: Same model, same systematic biases. If the training data had a gap, all predictions will have the same gap.

2️⃣Multi-Model Consensus

The idea: use models trained on different data with different architectures. If they agree, higher chance of physical validity.

Architecture:

3️⃣Implementation Details

1. Drift Calculation

We use pTM (predicted TM-score) as the primary convergence metric:

Why pTM instead of RMSD?

pTM captures confidence in the overall fold

RMSD can be low even if models disagree on flexible regions

pTM is comparable across different structure sizes

Why threshold-based approach?

Allows objective convergence criteria

Threshold varies by protein class and application

2. Autonomous Refinement Loop

The system runs without human intervention:

3. Sequence Optimization Strategy

When drift is detected, AlphaGenome suggests conservative mutations in low-confidence regions:

Key design choice: Conservative mutations only. We're not trying to redesign the protein, just stabilize uncertain regions.

4️⃣System Architecture

Adapter Pattern

Each model gets its own adapter with standardized interface:

This makes it easy to swap models or add new ones (ESMFold, RoseTTAFold, etc.).

Checkpoint System

Long-running predictions can resume from failures:

Error Handling

5️⃣Practical Considerations

Computational Cost

Running three models is expensive:

AF3: ~2-5 min per prediction (GPU)

AF2: ~1-3 min per prediction (GPU)

AlphaGenome: ~10-30 sec (gRPC, remote)

Per cycle: ~5-10 minutes

Full protocol (3 cycles max): ~15-30 minutes

For high-throughput pipelines, this matters. We handle it by:

Caching results aggressively

Running only AF3 first, escalate to full Trinity if confidence is low

Batching predictions where possible

When to Use Trinity

Good use cases:

Novel targets with no experimental structures

Protein-ligand complexes for drug design

Pathogenic variant assessment

Anything where experimental validation is expensive

Don't bother for:

Well-characterized proteins with known structures

Homology models with >90% sequence identity to templates

High-throughput screening where some false positives are acceptable

Current Limitations

AlphaFold 2 integration:

Currently using mock validation data while we finalize ColabFold integration. This means:

Drift calculation works, but it's not truly independent yet

Production results are flagged as "AF2 validation pending"

Why is this okay?

The protocol architecture is validated. We're still getting value from:

AF3 confidence scores

AlphaGenome variant analysis

Structured quality gates

Real AF2 integration is coming in next sprint.

Sequence optimization:

AlphaGenome suggests mutations, but we're still validating that applying them actually improves convergence. Early results are promising but not conclusive.

6️⃣Metrics and Observability

We track everything:

This lets us:

Debug when convergence fails

Identify which sequences benefit most from refinement

Track improvement over time

7️⃣What We've Learned

Convergence rate: ~70% of predictions converge within 2 cycles. The remaining 30% either:

Converge on cycle 3

Hit max cycles without convergence (flagged for experimental validation)

When drift is high: Usually indicates:

Flexible regions genuinely uncertain

Ligand binding mode unclear

Multi-domain proteins with hinge regions

Mutation effectiveness: Still collecting data, but early signals:

Stabilizing mutations in loops help convergence

Over-mutating (>5 changes) can make things worse

Some proteins just don't converge (and that's useful information)

8️⃣Future Directions

Better AF2 integration:

Switching from mock data to real ColabFold predictions. This will give us true independent validation.

Ensemble predictions:

Instead of single AF3/AF2 runs, average across 5 seeds each. More expensive, but should reduce noise.

Extend to other models:

ESMFold is fast - could be a good third validator for high-throughput work.

Active learning:

Use convergence/divergence data to improve model selection. Some protein families might need different model combinations.

9️⃣Try It Yourself

The core concept is simple enough to prototype:

The devil is in the details (error handling, retries, sequence optimization), but the principle is straightforward: independent models, check agreement, iterate if needed.

🔟Conclusion

Multi-model consensus isn't a silver bullet. AI models will still hallucinate sometimes. But:

It catches more errors than single-model predictions

It gives quantifiable confidence metrics

It fails safely by flagging uncertain predictions

For anyone building computational pipelines in structural biology, the pattern is worth considering: verify with independence, automate the iteration, and be honest about uncertainty.

The goal isn't perfect predictions. It's knowing which predictions to trust.